Novartis Ag NVS
NYSE NVS
$146.91 +1.45 (+1.00%)
As of: Sep 28, 2026 · 3:59 PM EDT

Novartis Ag (NVS) Long-Term Debt Repayments (2018)

Updated

Novartis Ag's Long-Term Debt Repayments was -$4 million in Q3 2018.

Analysis

Novartis Ag (NVS) Long-Term Debt Repayments (2018) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Repayment (Qtr)
1 Johnson & Johnson 653.54 Bn 572.07 Bn 17.26 Bn 1.00 Mn
2 AbbVie 467.01 Bn 440.17 Bn 12.70 Bn 2.00 Bn
3 Merck 367.16 Bn 321.59 Bn 12.21 Bn 5.00 Mn
4 Novartis Ag 277.56 Bn 233.43 Bn 11.24 Bn -
5 Astrazeneca 258.23 Bn 231.79 Bn 12.86 Bn -2.45 Bn
6 Amgen 224.14 Bn 179.54 Bn 7.24 Bn -
7 Gilead Sciences 187.30 Bn 161.42 Bn 6.22 Bn 17.00 Mn
8 Pfizer 163.47 Bn 110.41 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 133.31 Bn 105.31 Bn 2.84 Bn -
10 Bristol Myers Squibb 128.45 Bn 79.72 Bn 9.25 Bn 1.22 Bn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2018 -4.00 Mn
API Access

Novartis Ag Long-Term Debt Repayments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-repayments&ticker=NVS&period=max&api_key=YOUR_API_KEY